Entasis Therapeutics Holdings Inc. announced the appointment of Eric Kimble as Chief Commercial Officer. Mr. Kimble will be responsible for the design and execution of a global commercial strategy, including sales and marketing operations. Mr. Kimble is an accomplished life sciences executive with over 25 years of experience in sales, marketing and commercialization. Before joining Entasis Therapeutics as an employee, he worked on a consulting basis for the Company, as well as for several other antibiotic companies. Previously, he held various leadership roles at Cubist Pharmaceuticals, including VP of Sales and Marketing during the accelerated growth phase of CUBICIN, and VP of Program and Portfolio Management.